OpenResearchAlpha

Journal of Breast Imaging · 5 Nov 2026

Clinical Implications of Background Parenchymal Enhancement on Breast MRI

Kathryn W Zamorah-index 4, Kristen Coffey, Stephanie Colvin, Brittany Dashevsky, Katerina Dodelzon, Santo Maimone, Jessica H Porembka, Wenhui Zhou, Sona A Chikarmane

0
Citations
no database records one yet
0
Citations in 2026
so far
4
Leading author's h-index
Kathryn W Zamora, in QAI's scholar index
84
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Breast MRI is an essential tool for breast cancer detection, evaluation, and characterization, offering greater sensitivity than mammography and ultrasound. Normal breast tissue demonstrates variable enhancement on MRI, known as background parenchymal enhancement (BPE), which reflects the physiologic enhancement of fibroglandular tissue after gadolinium administration. Initially considered an incidental finding, BPE is now recognized as a dynamic imaging feature influenced by several factors, including age, menopausal status, exogenous hormone use, and prior breast cancer treatments. Increasing evidence supports its clinical relevance since variations in BPE have been associated with differences in breast cancer risk, lesion detection, and imaging interpretation. Background parenchymal enhancement (BPE) is emerging as an important imaging biomarker with potential applications in risk stratification, evaluation of disease extent, and monitoring response to neoadjuvant therapy. Differences in BPE patterns may also correlate with tumor biology and molecular subtypes, further supporting its role in personalized breast imaging assessment. This article provides a comprehensive review of BPE, highlighting its biologic basis, imaging characteristics, and clinical implications in breast cancer care. It also examines the evolving role of artificial intelligence tools in the assessment and quantification of BPE, which may improve standardization and integration into clinical decision-making and research.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Kathryn W Zamora has the highest h-index among the authors (4).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (9)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (84)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 64 more references

A free account opens the rest of the citing papers and references on every paper’s page.